Related Experiment Video
Updated: Jun 24, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Assessing the correlation between the degree of tricuspid regurgitation and pulmonary hypertension: A comprehensive
Jamilah S AlRahimi1, Yasser M Ismail1, Noor A Aljubairi1
1From the Department of Cardiology (AlRahimi, Ismail, Ahmed, Haneef); from the Department of Cardiothoracic Surgery (Haneef), King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from King Abdullah International Medical Research Center (AlRahimi, Ismail, Aljubairi, Kutob, Bakulka), from the College of Medicine (AlRahimi); from the College of Applied Medical Sciences (Ismail, Aljubairi, Kutob, Bakulka), King Saud bin Abdulaziz University for Health Sciences, and from the College of Medicine (Ahmed), Batterjee Medical College for Science and Technology, Jeddah, Kingdom of Saudi Arabia.
Objectives:
To evaluate the relationship between severity of tricuspid regurgitation (TR) and pulmonary hypertension.
Methods:
Cross-sectional study of 118 patients with pulmonary hypertension was carried out at a single center in Jeddah, Saudi Arabia, between 2018-2021. Patients who had pulmonary or tricuspid valves organic diseases, previously undergone tricuspid or pulmonary valve surgeries, had permanent pacemakers or critically ill were excluded.
Results:
A high proportion of patients were women (n=100, 85%) and obese (n=57, 48%). Patients with more than mild TR had higher systolic pulmonary artery pressure (sPAP) than those with trivial or mild regurgitation (p<0.001). There was a significant association between severity of TR (p<0.001) and right chambers size (p=0.001). Furthermore, pulmonary artery pressure (PAP) was significantly higher in patients with mild right ventricular impairment (p=0.001).
Conclusion:
Increase in degree of TR and right atrial size were predictors of elevated sPAP. Our findings highlight the interplay among TR, right heart size, ventricular function, and PAP. Understanding these associations can aid in risk stratification, monitoring disease progression, and potentially guiding treatment in those patients.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Measurement of Blood Pressure
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

